99m Tc- 68 Ga-ICG-Labelled Macroaggregates and Nanocolloids of Human Serum Albumin: Synthesis Procedures of a Trimodal Imaging Agent Using Commercial Kits
Recent developments in sentinel lymph node (SLN) and radio occult lesion localization (ROLL) highlight the need for a multimodal contrast agent, providing better presurgical PET imaging and improved intraoperative mapping thanks to fluorescence detection. For this reason, we have studied a trimodal...
Saved in:
Published in | Contrast media and molecular imaging Vol. 2020; pp. 1 - 11 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
22.01.2020
|
Online Access | Get full text |
Cover
Loading…
Summary: | Recent developments in sentinel lymph node (SLN) and radio occult lesion localization (ROLL) highlight the need for a multimodal contrast agent, providing better presurgical PET imaging and improved intraoperative mapping thanks to fluorescence detection. For this reason, we have studied a trimodal SLN/ROLL targeting agent (
99m
Tc-
68
Ga-ICG) with commercially available kits of macroaggregated or nanocolloidal albumin (MA/NC-HSA).
68
Ga PET imaging does provide better spatial resolution and makes it possible to predict signal intensity during surgery. The presence of
99m
Tc assesses the efficacy of these compounds
in vitro
and also during the surgery procedure. The aim of this study was to optimise the labelling and tagging of these two radiopharmaceuticals and assess their yields and stability. Kits of MA/NC-HSA particles (Pulmocis® and NanoAlbumon®) were used for sequential radiolabelling with
99m
Tc and
68
Ga. Fluorescent tagging was performed using indocyanine green, a tricarbocyanine dye. The ITLC radiochemical purity of the trilabelled MA/NC-HSA was >95%. Fluorescent purity was measured by scanning the strips with a PhotoDynamicEye probe. Finally,
in vitro
stability tests, performed with DTPA and human serum solutions, assessed the efficacy of fluorescent tagging and radiolabelling. |
---|---|
ISSN: | 1555-4309 1555-4317 |
DOI: | 10.1155/2020/3629705 |